1. Home
  2. BBLG vs GCTK Comparison

BBLG vs GCTK Comparison

Compare BBLG & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BBLG

Bone Biologics Corp

HOLD

Current Price

$1.46

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Logo GlucoTrack Inc.

GCTK

GlucoTrack Inc.

HOLD

Current Price

$0.37

Market Cap

3.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBLG
GCTK
Founded
2004
2001
Country
United States
United States
Employees
2
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
3.0M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
BBLG
GCTK
Price
$1.46
$0.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
37.2K
601.2K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.65
Revenue
N/A
$589,462.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.14
Revenue Growth
N/A
N/A
52 Week Low
$1.05
$0.29
52 Week High
$4.13
$15.90

Technical Indicators

Market Signals
Indicator
BBLG
GCTK
Relative Strength Index (RSI) 64.18 30.39
Support Level $1.24 $0.29
Resistance Level $1.88 $1.02
Average True Range (ATR) 0.09 0.07
MACD 0.03 -0.01
Stochastic Oscillator 75.76 19.08

Price Performance

Historical Comparison
BBLG
GCTK

About BBLG Bone Biologics Corp

Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.

Share on Social Networks: